193 related articles for article (PubMed ID: 32922169)
1. Rapamycin blocks the IL-13-induced deficiency of Epidermal Barrier Related Proteins via upregulation of miR-143 in HaCaT Keratinocytes.
Jia QN; Zeng YP
Int J Med Sci; 2020; 17(14):2087-2094. PubMed ID: 32922169
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1.
Zeng YP; Nguyen GH; Jin HZ
Mol Cell Biochem; 2016 May; 416(1-2):63-70. PubMed ID: 27048505
[TBL] [Abstract][Full Text] [Related]
3. CYT387, a Novel JAK2 Inhibitor, Suppresses IL-13-Induced Epidermal Barrier Dysfunction Via miR-143 Targeting IL-13Rα1 and STAT3.
Zu Y; Chen XF; Li Q; Zhang ST
Biochem Genet; 2021 Apr; 59(2):531-546. PubMed ID: 33190168
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.
Furue M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751111
[TBL] [Abstract][Full Text] [Related]
5. Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis.
Lee J; Song KM; Jung CH
Phytomedicine; 2021 Jan; 81():153418. PubMed ID: 33302042
[TBL] [Abstract][Full Text] [Related]
6. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
[TBL] [Abstract][Full Text] [Related]
7. Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes.
Ulzii D; Kido-Nakahara M; Nakahara T; Tsuji G; Furue K; Hashimoto-Hachiya A; Furue M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284553
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes.
Zhao J; Benakanakere MR; Hosur KB; Galicia JC; Martin M; Kinane DF
Mol Immunol; 2010; 48(1-3):294-304. PubMed ID: 20728939
[TBL] [Abstract][Full Text] [Related]
9. High glucose up-regulates Semaphorin 3A expression via the mTOR signaling pathway in keratinocytes: A potential mechanism and therapeutic target for diabetic small fiber neuropathy.
Wu LY; Li M; Qu ML; Li X; Pi LH; Chen Z; Zhou SL; Yi XQ; Shi XJ; Wu J; Wang S
Mol Cell Endocrinol; 2018 Sep; 472():107-116. PubMed ID: 29203371
[TBL] [Abstract][Full Text] [Related]
10. A study on regulatory mechanism of miR-223 in ulcerative colitis through PI3K/Akt-mTOR signaling pathway.
Jiang W; Han YP; Hu M; Bao XQ; Yan Y; Chen G
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4865-4872. PubMed ID: 31210320
[TBL] [Abstract][Full Text] [Related]
11. MRGPRX2 antagonist GE1111 attenuated DNFB-induced atopic dermatitis in mice by reducing inflammatory cytokines and restoring skin integrity.
Wong TK; Choi YG; Li PH; Chow BKC; Kumar M
Front Immunol; 2024; 15():1406438. PubMed ID: 38817611
[TBL] [Abstract][Full Text] [Related]
12. miR-125b inhibits keratinocyte proliferation and promotes keratinocyte apoptosis in oral lichen planus by targeting MMP-2 expression through PI3K/Akt/mTOR pathway.
Wang J; Luo H; Xiao Y; Wang L
Biomed Pharmacother; 2016 May; 80():373-380. PubMed ID: 27133077
[TBL] [Abstract][Full Text] [Related]
13. Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes.
Xu S; Li L; Li M; Zhang M; Ju M; Chen X; Gu H
Oxid Med Cell Longev; 2017; 2017():5930639. PubMed ID: 28400912
[TBL] [Abstract][Full Text] [Related]
14. An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip.
Kim K; Kim H; Sung GY
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216228
[TBL] [Abstract][Full Text] [Related]
15. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.
Pellerin L; Henry J; Hsu CY; Balica S; Jean-Decoster C; Méchin MC; Hansmann B; Rodriguez E; Weindinger S; Schmitt AM; Serre G; Paul C; Simon M
J Allergy Clin Immunol; 2013 Apr; 131(4):1094-102. PubMed ID: 23403047
[TBL] [Abstract][Full Text] [Related]
16. Topical application of rapamycin ointment ameliorates Dermatophagoides farina body extract-induced atopic dermatitis in NC/Nga mice.
Yang F; Tanaka M; Wataya-Kaneda M; Yang L; Nakamura A; Matsumoto S; Attia M; Murota H; Katayama I
Exp Dermatol; 2014 Aug; 23(8):568-72. PubMed ID: 24903639
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
[TBL] [Abstract][Full Text] [Related]
18. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
[TBL] [Abstract][Full Text] [Related]
19. A molecular mechanism for IL-4 suppression of loricrin transcription in epidermal keratinocytes: implication for atopic dermatitis pathogenesis.
Bao L; Mohan GC; Alexander JB; Doo C; Shen K; Bao J; Chan LS
Innate Immun; 2017 Nov; 23(8):641-647. PubMed ID: 28952836
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis.
Wongpiyabovorn J; Suto H; Ushio H; Izuhara K; Mitsuishi K; Ikeda S; Nakao A; Okumura K; Ogawa H
J Dermatol Sci; 2003 Oct; 33(1):31-40. PubMed ID: 14527737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
